- Focus and Scope
- Section Policies
- Peer Review Process
- Publication Frequency
- Open Access Policy
- Publication Ethics
- Editorial Policies
- Author Fees
- Publication Frequency
- Digital Archiving
- Plagiarism Policy
- Order Journal
- Indexing & Abstracting
- Adress
- Review Guidelines
Focus and Scope
The journal includes various fields of pharmaceuticals sciences such as:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Section Policies
Research Article
![]() |
![]() |
![]() |
Review Article
![]() |
![]() |
![]() |
Front Matter Vol. 14 No.1 January 2023
![]() |
![]() |
![]() |
Peer Review Process
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. |
Review Process of Manuscript: Initial Review
Full Review Process of Manuscript
|
Publication Frequency
Jurnal Ilmiah Farmako Bahari published in January and July.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.
Publication Ethics
Publication Ethics and Malpractice Statement
Jurnal Ilmiah Farmako Bahari is committed to upholding the highest standards of publication ethics and taking all possible action against publication malpractices. This publication ethics and malpractice statement is compiled from various credible sources, such as Principles of Transparency and Best Practice in Scholarly Publishing from the Committee on Publication Ethics (COPE).
Ethical Guideline for Journal Publication
The publication of an article in a peer-reviewed Jurnal Ilmiah Farmako Bahari is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher as well as the society.
Faculty of Mathematic and Natural Science, Garut University, Indonesia as the publisher of Jurnal Ilmiah Farmako Bahari takes its duties of guardianship over all stages of publishing extremely seriously and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or other commercial revenue has no impact or influence on editorial decisions. In addition, the Faculty of Mathematic and Natural Science, Garut University, and Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary.
The following statement describes the ethical behavior of all parties involved in the act of publishing articles for the Jurnal Ilmiah Farmako Bahari, namely: editors, peer reviewers, and authors.
1. Duties of Editors
1.1 Publication Decision
The editor of the Jurnal Ilmiah Farmako Bahari is responsible for deciding which of the articles submitted to the journal should be accepted for publication. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision. The journal used Viper Plagiarism Scanner to detect the possibilities of plagiarism in the manuscript.
1.2 Fair play
An editor at any time evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
1.3 Confidentiality
The editor and any editorial board member must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, other editorial advisers, and the publisher, as appropriate.
1.4. Disclosure and Conflicts of Interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.
1.5. Involvement and Cooperation in Investigations
The editor must take sufficiently responsive steps when ethical complaints regarding manuscripts submitted in relation to the publisher (or the public) are found.
These steps generally include contacting the authors of the manuscript and giving consideration to the respective complaints or claims that have been made, further communication to the relevant agencies and research bodies and if the complaint has been upheld then publication corrections, recalls, expressions of apologies. , or other notes that may be relevant.
Any reported act of unethical behavior in publication should be kept under scrutiny even if it is discovered several years after publication.
2. Duties of Reviewers
2.1 Contribution to Editorial Decisions
Reviewer(s) assists the editorial team in making editorial decisions and through the editorial communications with the author. Besides, the reviewer(s) may also assist the author in improving the paper.
2.2 Promptness
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
2.3 Confidentiality
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
2.4 Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
2.5 Source Acknowledgment
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
2.6 Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Duties of Authors
3.1 Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical conduct and are unacceptable.
3.2 Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should, in any event, be prepared to retain such data for a reasonable time after publication.
3.3 Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
3.4 Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing conduct and is unacceptable.
3.5 Acknowledgment of Sources
Proper acknowledgment of the work of others should always be in writing. Authors must cite publications that have influenced the research being reported. Information obtained privately, such as in conversations, correspondence, or discussions with third parties must not be used or reported without written permission from the source. Information obtained in the course of confidential service such as jury manuscripts or grant applications may not be used without written permission from the authors involved.
3.6 Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
3.7 Hazards and Human or Animal Subjects
If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. The procedures related to humans or animals should be approved by the Ethics Committee and/or refer to the standard procedures.
3.8 Natural Medicine Materials
A study using natural medicine materials should provide the latin names, nomenclature author, family name (in parentheses), the source, extraction/fractionation methods for all collected materials used in the study. Pharmacological Evaluation of the materials should use a reference (positive control).
3.9. Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or another substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
3.10 Fundamental Errors in Published Works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper
Editorial Policies
Scientific Journal of Farmako Bahari editorial policies regarding scientific research publications can be reviewed below.
Peer-Review Process
A manuscript submitted is evaluated through Initial Review by Editorial Board. If the article matchs the journal requirements in term of the scope, originality, novelty sufficiency of experimental data and format, at least 2 (two) peer reviewers are assigned to review the manuscript with Blind Review Process. Three weeks are alocation time given to peer revewer to evaluate the manuscipt. After review process is finished, the assigned editor makes decision for the article. If the article needs revision, the manuscript is returned to the authors to revise. These processes take a month (maximum time). If the decision is major revision or resubmission, revised manuscript that has been resubmitted by submitter is sent back to the previous peer reviwers for re-evaluation. After that, the editor makes final decision (accepted or rejected). In the each manuscript reviewed, peer reviewers will be rated based on the substantial and technical aspects. Assigment of peer reviewer is based on the expertise and experiences in research and publication relevant to the field of manuscript to be reviewed. Number of citation and h-index value of peer reviewers are parameter examples for consideration in assigning as reviewer.
Rapid Peer-Review Process
Jurnal Ilmiah Farmako Bahari does not accept requests for the rapid peer-review process at all. All manuscripts submitted to Jurnal Ilmiah Farmako Bahari will be treated the same as described in the peer-review process section.
Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.
Informed Consent
For research related to human subjects, the investigators must ask for the consent of the candidate subject through informed consent and the procedure must be conveyed in the research protocol submitted to the research ethics committee. With the approval of the research protocol by the ethics committee, the informed consent procedure was also approved. However, the authors must be able to provide evidence documents of the subjects' informed consent when requested by the editorial board for clarification at any time.
Hazards and Human or Animal Subjects
The procedures related to humans or animals should be approved by the Ethics Committee and/or refer to the standard procedures, and evidenced by a statement in the manuscript informing the name of the institution/research ethics committee and the ethic number obtained. If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the author could not provide it, the Jurnal Ilmiah Farmako Bahari will decline submission.
Data Sharing and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should, in any event, be prepared to retain such data for a reasonable time after publication.
Presubmission Inquiry
Jurnal Ilmiah Farmako Bahari only accepts pre-submission inquiries via email to [email protected] with the subject title "Presubmission Inquiry".
No Prior Publication
Jurnal Ilmiah Farmako Bahari only accepts publication manuscripts that have never been submitted to and/or published in other journals or proceedings.
Scientific Meetings
In the event of a scientific meeting in collaboration with the Jurnal Ilmiah Farmako Bahari, the peer-review process will still be carried out by the Jurnal Ilmiah Farmako Bahari and will be treated the same as described in the peer-review process section (no rapid peer-review process).
Author Fees
This journal charges the following author fees.
Article Submit: IDR 100.000
Article Review: IDR 200.000
Article Publication: IDR 400.000
Starting from January, 2st 2021, any accepted manuscript for publication will be charged for IDR 700.000 per manuscript as the Publication Fee.
Payments should be performed via transfer to BNI (Account holder: BNI FMIPA FARMASI No. VA: 0360289921)
For further information regarding our Article Publication Fee, please contact us via e-mail on [email protected]
Publication Frequency
Jurnal Ilmiah Farmako Bahari published in January and July.
Digital Archiving
This journal utilizes the Indonesia One Search (IOS) and Garuda system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.
Plagiarism Policy
Jurnal Ilmiah Farmako Bahari state that plagiarism is not acceptable for all author and therefore establishes the following policy stating specific actions (penalties) when plagiarism is identified by plagiarism cheker software in an article that is submitted for publication. We are using Turnitin as the plagiarism checker software. “Plagiarism is copying another person’s text or ideas and passing the copied material as your own work. You must both delineate (i.e., separate and identify) the copied text from your text and give credit to (i.e., cite the source) the source of the copied text to avoid accusations of plagiarism. Plagiarism is considered fraud and has potentially harsh consequences including loss of job, loss of reputation, and the assignation of reduced or failing grade in a course." This definition of plagiarism applies for copied text and ideas:
When plagiarism is identified by the Plagiarism Checker software, the Editorial Board responsible for the review of this paper and will agree on measures according to the extent of plagiarism detected in the article in agreement with the following guidelines: Minor Plagiarism A small sentence or short paragraph of another manuscript is plagiarized without any significant data or idea taken from the other papers or publications. Punishment: A warning is given to the authors and a request to change the manuscript and properly cite the original sources. Intermediate Plagiarism A significant data, paragraph, or sentence of an article is plagiarized without proper citation to the original source. Punishment: The submitted article is automatic rejected. Severe Plagiarism A large portion of an article is plagiarized that involves many aspects such as reproducing original results (data, formulation, equation, law, statement, etc.), ideas, and methods presented in other publications. Punishment: The paper is automatic rejected and the authors are forbidden to submit further articles to the journal. Retraction The articles published in Jurnal Ilmiah Farmako Bahari will be considered to retract in the publication if:
The mechanism of retraction follow the Retraction Guidelines of Committee on Publication Ethics (COPE) which can be accessed at https://publicationethics.org/sites/default/files/retraction-guidelines-cope.pdf |
Order Journal
All orders for hardcopy of the journal may be sent via email to [email protected] with the subject Order Journal. For customers, annual subscription rate is IDR 500,000.00. All rates exclude 15% shipping. The order will be executed when payment have been performed and the payment may be conducted via transfer to BNI (Account holder: BNI FMIPA FARMASI Account-VA 0360289921).
Indexing & Abstracting
Jurnal Ilmiah Farmako Bahari registered number ISSN 2087-0337 (print) and 2715-9949 (online) has been indexed on:
Google Scholar link:
Indexed by:
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
Adress
FAKULTAS MATEMATIKA DAN ILMU PENGETAHUAN ALAM, UNIVERSITAS GARUT
Jalan Jati No 42B Tarogong Kaler Garut Jawa Barat
(0262) 540007
(0262) 544-217
Email : [email protected]

Jurnal Farmako Bahari Universitas Garut Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-BerbagiSerupa 4.0 Internasional.
Review Guidelines
Review Process of Manuscript: Initial Review
Full Review Process of Manuscript
|